For a variety of medical applications, Kromek supplies OEMs with customisable or complete CZT based detection solutions to improve patient outcomes worldwide and ultimately make the world a healthier and safer place.
Kromek's CEO, Dr Arnab Basu, recently spoke with BBC Radio Tees about the work being done by the Kromek team and partners to make breast cancer screening technology more effective for women with dense breasts.